Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Baba, Yoshifumi ^a   Huttenhower, Curtis ^b   Nosho, Katsuhiko ^a   Tanaka, Noriko ^a,b   Shima, Kaori ^a   Hazra, Aditi ^b,c   Schernhammer, Eva S ^b,c,d   Hunter, David J ^b,c   Giovannucci, Edward L ^b,c   Fuchs, Charles S ^a,c   Ogino, Shuji ^a,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLOOXYGENASE 2; K RAS PROTEIN; PROTEIN P53; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER STAGING; COHORT ANALYSIS; COLORECTAL CANCER; DNA METHYLATION; EPIGENETICS; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENETIC DATABASE; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY; PYROSEQUENCING; RECEIVER OPERATING CHARACTERISTIC; RETROPOSON; SMOKING; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION; AREA UNDER THE CURVE; COLORECTAL TUMOR; GENETIC EPIGENESIS; GENETICS; GENOMIC INSTABILITY; LONG INTERSPERSED REPEAT; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGE FACTORS; AREA UNDER CURVE; COHORT STUDIES; COLORECTAL NEOPLASMS; DATABASES, GENETIC; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOMIC INSTABILITY; HUMANS; IMMUNOHISTOCHEMISTRY; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MICROSATELLITE INSTABILITY; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 77952712959     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-125     Document Type: Article

References (69)

1. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007, 128(4):683-692. 10.1016/j.cell.2007.01.029, 17320506.
2. Bestor TH. Transposons reanimated in mice. Cell 2005, 122(3):322-325. 10.1016/j.cell.2005.07.024, 16096053.
3. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300(5618):489-492. 10.1126/science.1083558, 12702876.
4. Yamada Y, Jackson-Grusby L, Linhart H, Meissner A, Eden A, Lin H, Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 2005, 102(38):13580-13585. 10.1073/pnas.0506612102, 1224663, 16174748.
5. Rodriguez J, Frigola J, Vendrell E, Risques RA, Fraga MF, Morales C, Moreno V, Esteller M, Capella G, Ribas M, Peinado MA. Chromosomal Instability Correlates with Genome-wide DNA Demethylation in Human Primary Colorectal Cancers. Cancer Res 2006, 66(17):8462-9468. 10.1158/0008-5472.CAN-06-0293, 16951157.
6. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K, Perucho M. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006, 9(3):199-207. 10.1016/j.ccr.2006.02.016, 16530704.
7. Karpf AR, Matsui S. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 2005, 65(19):8635-8639. 10.1158/0008-5472.CAN-05-1961, 16204030.
8. Lim U, Flood A, Choi SW, Albanes D, Cross AJ, Schatzkin A, Sinha R, Katki HA, Cash B, Schoenfeld P, Stolzenberg-Solomon R. Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology 2008, 134(1):47-55. 10.1053/j.gastro.2007.10.013, 2211566, 18166347.
9. Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet 2009, 10(10):691-703. 10.1038/nrg2640, 19763152.
10. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004, 32(3):e38. 10.1093/nar/gnh032, 373427, 14973332.
11. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005, 33(21):6823-6836. 10.1093/nar/gki987, 1301596, 16326863.
12. Yang AS, Doshi KD, Choi SW, Mason JB, Mannari RK, Gharybian V, Luna R, Rashid A, Shen L, Estecio MR, Kantarjian HM, Garcia-Manero G, Issa JP. DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia. Cancer Res 2006, 66(10):5495-5503. 10.1158/0008-5472.CAN-05-2385, 16707479.
13. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol 2001, 21(6):1973-1985. 10.1128/MCB.21.6.1973-1985.2001, 86790, 11238933.
14. Peaston AE, Evsikov AV, Graber JH, de Vries WN, Holbrook AE, Solter D, Knowles BB. Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos. Dev Cell 2004, 7(4):597-606. 10.1016/j.devcel.2004.09.004, 15469847.
15. Faulkner GJ, Kimura Y, Daub CO, Wani S, Plessy C, Irvine KM, Schroder K, Cloonan N, Steptoe AL, Lassmann T, Waki K, Hornig N, Arakawa T, Takahashi H, Kawai J, Forrest AR, Suzuki H, Hayashizaki Y, Hume DA, Orlando V, Grimmond SM, Carninci P. The regulated retrotransposon transcriptome of mammalian cells. Nat Genet 2009, 41(5):563-571. 10.1038/ng.368, 19377475.
16. Han JS, Szak ST, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004, 429(6989):268-274. 10.1038/nature02536, 15152245.
17. Howard G, Eiges R, Gaudet F, Jaenisch R, Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008, 27(3):404-408. 10.1038/sj.onc.1210631, 17621273.
18. Estecio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, Tajara EH, Issa JP. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS ONE 2007, 2(5):e399. 10.1371/journal.pone.0000399, 1851990, 17476321.
19. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG methylator phenotype in colorectal cancer. Int J Cancer 2008, 122:2767-2773. 10.1002/ijc.23470, 2630175, 18366060.
20. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 2008, 100:1734-1738. 10.1093/jnci/djn359, 2639290, 19033568.
21. Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009, 137(5):1609-1620. e1603., 10.1053/j.gastro.2009.08.002, 19686742.
22. Chan AT, Ogino S, Fuchs CS. Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2. New Engl J Med 2007, 356(21):2131-2142. 10.1056/NEJMoa067208, 17522398.
23. Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Meyerhardt JA, Fuchs CS. Prognostic significance and molecular associations of 18 q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. J Clin Oncol 2009, 26(35):5713-5720.
24. Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Meyerhardt JA, Fuchs CS, Ogino S. Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer. Neoplasia 2007, 9(7):569-577. 10.1593/neo.07334, 1939932, 17710160.
25. Ogino S, Odze RD, kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, Loda M, Fuchs CS. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol 2006, 30(9):1175-1183.
26. Ogino S, kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 2006, 8(2):209-217. 10.2353/jmoldx.2006.050135, 1867588, 16645207.
27. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28(8):E32. 10.1093/nar/28.8.e32, 102836, 10734209.
28. Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner G, Weisenberger DJ, Campan M, Laird PW, Loda M, Fuchs CS. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006, 55:1000-1006. 10.1136/gut.2005.082933, 1856352, 16407376.
29. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006, 38(7):787-793. 10.1038/ng1834, 16804544.
30. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS ONE 2008, 3(11):e3698. 10.1371/journal.pone.0003698, 2579485, 19002263.
31. Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 2007, 9(3):305-314. 10.2353/jmoldx.2007.060170, 1899428, 17591929.
32. Irahara N, Nosho K, Baba Y, Shima K, Lindeman NI, Hazra A, Schernhammer ES, Hunter DJ, Fuchs CS, Ogino S. Precision of Pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa and peripheral blood cells. J Mol Diagn 2010, 12(2):177-183. 10.2353/jmoldx.2010.090106, 20093385.
33. Burden AF, Manley NC, Clark AD, Gartler SM, Laird CD, Hansen RS. Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements. J Biol Chem 2005, 280(15):14413-14419. 10.1074/jbc.M413836200, 15710616.
34. Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, Mino-Kenudson M, Lauwers GY, Loda M, Fuchs CS. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn 2005, 7(3):413-421. 1867544, 16049314.
35. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 2006, 8:582-588. 10.2353/jmoldx.2006.060082, 1876166, 17065427.
36. Nosho K, Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Zepf D, Yan L, Longtine JA, Fuchs CS, Ogino S. PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. Neoplasia 2008, 10(6):534-541. 2386538, 18516290.
37. Ogino S, Nosho K, Kirkner GJ, Shima K, Irahara N, Kure S, Chan AT, Engelman JA, Kraft P, Cantley LC, Giovannucci EL, Fuchs CS. PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. J Clin Oncol 2009, 27:1477-1484. 10.1200/JCO.2008.18.6544, 2659340,2659340, 19237633.
38. Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M, Fuchs CS. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 2006, 19(1):59-68. 10.1038/modpathol.3800482, 16118624.
39. Baba Y, Nosho K, Shima K, Irahara N, Kure S, Toyoda S, Kirkner GJ, Goel A, Fuchs CS, Ogino S. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia 2009, 11(5):418-425. 2671854, 19412426.
40. Nosho K, Shima K, Kure S, Irahara N, Baba Y, Chen L, Kirkner GJ, Fuchs CS, Ogino S. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Neoplasia 2009, 11(1):87-95. 2606122, 19107235.
41. Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Neoplasia 2006, 8(6):458-464. 10.1593/neo.06247, 1601473, 16820091.
42. Ogino S, kawasaki T, Kirkner GJ, Yamaji T, Loda M, Fuchs CS. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod Pathol 2007, 20:15-22. 10.1038/modpathol.3800709, 17086168.
43. Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS. Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Clin Cancer Res 2005, 11(18):6650-6656. 10.1158/1078-0432.CCR-05-0738, 16166444.
44. Ogino S, kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol 2006, 210(2):147-154. 10.1002/path.2030, 16850502.
45. Ogino S, Nosho K, Meyerhardt JA, Kirkner GJ, Chan AT, Kawasaki T, Giovannucci EL, Loda M, Fuchs CS. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol 2008, 26(35):5713-5720. 10.1200/JCO.2008.18.2675, 2630484,2630484, 18955444.
46. Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, Meltzer SJ, Wright C, Searle J, Young J, Leggett BA. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999, 52(6):455-460. 10.1136/jcp.52.6.455, 501434, 10562815.
47. Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM, Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 2005, 8(4):275-285. 10.1016/j.ccr.2005.09.007, 16226703.
48. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V, Mutirangura A. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004, 23(54):8841-8846. 10.1038/sj.onc.1208137, 15480421.
49. Matsuzaki K, Deng G, Tanaka H, Kakar S, Miura S, Kim YS. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 2005, 11(24):8564-8569. 10.1158/1078-0432.CCR-05-0859, 16361538.
50. Ji W, Hernandez R, Zhang XY, Qu GZ, Frady A, Varela M, Ehrlich M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res 1997, 379(1):33-41.
51. Derks S, Postma C, Carvalho B, Bosch SM, Moerkerk PT, Herman JG, Weijenberg MP, de Bruine AP, Meijer GA, van Engeland M. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis 2008, 29(2):434-439. 10.1093/carcin/bgm270, 18048385.
52. Iacopetta B, Grieu F, Phillips M, Ruszkiewicz A, Moore J, Minamoto T, Kawakami K. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 2007, 98(9):1454-1460. 10.1111/j.1349-7006.2007.00548.x, 17640302.
53. Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, Chen X, Bresalier RS, McKeown-Eyssen G, Haile RW, Baron JA, Issa JP. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1041-1049. 10.1158/1055-9965.EPI-08-0926, 2712652, 19336559.
54. Goodier JL, Kazazian HH. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008, 135(1):23-35. 10.1016/j.cell.2008.09.022, 18854152.
55. Schulz WA. L1 retrotransposons in human cancers. J Biomed Biotechnol 2006, 2006(1):83672. 1559935, 16877821.
56. Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci 2009, 66(14):2249-2261. 10.1007/s00018-009-0015-5, 19326048.
57. Shahrzad S, Bertrand K, Minhas K, Coomber BL. Induction of DNA hypomethylation by tumor hypoxia. Epigenetics 2007, 2(2):119-125.
58. Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 2010, 176(5):2292-2301. 10.2353/ajpath.2010.090972, 20363910.
59. Nakamura Y, Yogosawa S, Izutani Y, Watanabe H, Otsuji E, Sakai T. A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol Cancer 2009, 8:100. 10.1186/1476-4598-8-100, 2784428, 19909554.
60. Prokunina-Olsson L, Hall JL. No effect of cancer-associated SNP rs6983267 in the 8 q24 region on co-expression of MYC and TCF7L2 in normal colon tissue. Mol Cancer 2009, 8:96. 10.1186/1476-4598-8-96, 2777153, 19895682.
61. Koslowski M, Tureci O, Huber C, Sahin U. Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2. Mol Cancer 2009, 8:77. 10.1186/1476-4598-8-77, 2759907, 19781065.
62. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O. Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover. Mol Cancer 2008, 7:72. 10.1186/1476-4598-7-72, 2569965, 18799019.
63. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer 2008, 7:94. 10.1186/1476-4598-7-94, 2639620, 19117505.
64. Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, Al-Mawaly K, Al-Mjeni R, Al-Sayegh A, Raeburn S, Lee E, Giardiello F, Smoot DT, Vilkin A, Boland CR, Goel A, Hafezi M, Nouraie M, Ashktorab H. Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer 2008, 7:68. 10.1186/1476-4598-7-68, 2551625, 18718023.
65. Teodoridis JM, Hardie C, Brown R. CpG island methylator phenotype (CIMP) in cancer: Causes and implications. Cancer Lett 2008, 268(2):177-186. 10.1016/j.canlet.2008.03.022, 18471961.
66. Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007, 56(1):140-148. 10.1136/gut.2005.088799, 1856668, 16840508.
67. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009, 9(7):489-499. 10.1038/nrc2645, 19536109.
68. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008, 135(4):1079-1099. 10.1053/j.gastro.2008.07.076, 2866182, 18773902.
69. Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, Ogino S. Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control 2010, (21):331-345. 10.1007/s10552-009-9464-2, 19936946.